Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy

Journal:
Nature Nanotechnology
Published:
DOI:
10.1038/s41565-025-02113-w
Affiliations:
2
Authors:
11
Go to article
Institutions Authors Share
State Key Laboratory of Natural Medicines (SKLNM), CPU, China
10.000000
10.000000
 0.91
China Pharmaceutical University (CPU), China
1.000000
 0.09
Interested in Oncology and Carcinogenesis?